Product correctly added to cart.

discount label
Veliparib dihydrochloride
View 3D

Biosynth logo

Veliparib dihydrochloride

CAS: 912445-05-7

Ref. 3D-MLB44505

100mgTo inquire
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
Veliparib dihydrochloride
Synonyms:
  • ABT-888.2HCl
  • Veliparib 2HCl
  • 2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide dihydrochloride
Description:

Veliparib is a pan-inhibitor of polymerase chain reaction (PCR) that inhibits the enzyme DNA polymerase. It has been shown to induce neuronal death and inhibit cell growth in vitro, as well as to reduce tumor size in vivo. Veliparib binds to the active site of DNA polymerase, thereby inhibiting its activity. The binding mechanism is competitive with respect to ATP and is reversible. Veliparib has been shown to be an effective inhibitor of Jak2 in v617F cells, which are found in about 15% of all solid tumours. Veliparib also inhibits the expression of proteins involved in cellular proliferation, such as cyclin D1 and c-Myc, which are associated with increased cancer risk.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
317.21 g/mol
Formula:
C13H16N4O·2HCl
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-MLB44505 Veliparib dihydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".